7Baggers
 RYTM: HC Wainwright Raises Price Target, Maintains Buy Rating |  GuruFocus Mon, 29 Sep 2025 11:22:51 GMT
 Morgan Stanley Maintains Overweight on Rhythm Pharmaceuticals (R  GuruFocus Thu, 25 Sep 2025 19:04:32 GMT
 goldman sachs raises price target for rytm to $138, maintains 'b  GuruFocus Wed, 24 Sep 2025 18:46:14 GMT
 2 under-the-radar stocks that could soar  MSN Wed, 24 Sep 2025 11:20:05 GMT
 3 stocks that may be undervalued by up to 49%  simplywall.st Tue, 23 Sep 2025 11:11:25 GMT
 strs ohio takes position in rhythm pharmaceuticals, inc. $rytm  MarketBeat Mon, 22 Sep 2025 20:30:29 GMT
 2 under-the-radar stocks that could soar  Mitrade Sun, 21 Sep 2025 15:32:15 GMT
 strs ohio buys new holdings in rhythm pharmaceuticals, inc. $rytm  MarketBeat Sun, 21 Sep 2025 08:34:02 GMT
 strs ohio invests $980,000 in rhythm pharmaceuticals, inc. $rytm  MarketBeat Fri, 19 Sep 2025 07:21:24 GMT
 rhythm pharmaceuticals stock surges on fda review news  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 14:38:46  Newser Fri, 05 Sep 2025 19:38:46 GMT
 published on: 2025-09-05 05:57:51  Newser Fri, 05 Sep 2025 10:57:51 GMT
 published on: 2025-09-04 07:45:10  Newser Thu, 04 Sep 2025 12:45:10 GMT
 published on: 2025-09-04 00:38:10  Newser Thu, 04 Sep 2025 05:38:10 GMT
 published on: 2025-09-02 04:29:59  Newser Tue, 02 Sep 2025 09:29:59 GMT
 published on: 2025-08-30 21:22:14  Newser Tue, 02 Sep 2025 05:55:18 GMT

Rhythm Pharmaceuticals, Inc
(NASDAQ:RYTM) 

RYTM stock logo

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of ...

Founded: 2008
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends